|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
0.02/1.11
|
Enterprise Value
3.50B
|
Balance Sheet |
Book Value Per Share
14.52
|
Cash Flow |
Cash Flow Yield
0.04
|
Income Statement |
Total Revenue
822.45M
|
Operating Revenue Per Share
4.24
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/10 06:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substancesin food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%. |